Skip to main content
Genus plc (GENSF)
OTCMKTS · Delayed Price · Currency is USD
21.00
0.00 (0.00%)
Dec 25, 2024, 4:00 PM EST

Genus Revenue

In the fiscal year ending June 30, 2024, Genus had annual revenue of 668.80M GBP, down -3.03%. Genus had revenue of 335.20M in the half year ending June 30, 2024, with 7.37% growth.

Revenue
668.80M GBP
Revenue Growth
-3.03%
P/S Ratio
n/a
Revenue / Employee
191.09K GBP
Employees
3,500
Market Cap
1.26B USD

Revenue Chart

* This company reports financials in GBP.

History

Fiscal Year End Revenue Change Growth
Jun 30, 2024668.80M-20.90M-3.03%
Jun 30, 2023689.70M96.30M16.23%
Jun 30, 2022593.40M19.10M3.33%
Jun 30, 2021574.30M22.90M4.15%
Jun 30, 2020551.40M62.90M12.88%
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro
Jun 30, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Sandoz Group AG 10.11B
Telix Pharmaceuticals Limited 430.80M
Elekta AB (publ) 1.66B
Ryman Healthcare Limited 458.44M
Verano Holdings Corp. 897.57M
Vireo Growth Inc. 98.53M
Medexus Pharmaceuticals Inc. 104.76M
Revenue Rankings

Genus News

More News